A new large-scale study conducted by the Cleveland Clinic on the effectiveness of the 2024–2025 influenza vaccine shows that ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

The global Influenza Vaccine Equipment Market is experiencing rapid growth, with a projected market valuation of US$ 51.53 billion by 2032, up from US$ 11.43 billion in 2023. This growth, which ...

Despite variations by age group and influenza virus type, the 2023-2024 influenza vaccine was protective against outpatient illness in pediatric and adult patients.

The global influenza vaccine market, valued at US$ 8.78 billion in 2023, is poised for remarkable growth, with projections indicating it will reach US$ 22.71 billion by 2032. This growth, representing ...

A recent study conducted by the Cleveland Clinic has revealed that this year's flu shot was not effective in preventing ...

Lablab beans naturally contain an antiviral trap protein (FRIL) which binds to viruses and prevents them from spreading ...

During the meeting, stakeholders discussed the implementation of an HPAI vaccine program in India. Currently, DAHD permits ...

Tasmania is facing a concerning rise in influenza cases, with infections up almost 60 per cent compared to the same time last year. At the same time, vaccination rates have dropped to their lowest ...

Kolkata: The city has been reeling under intense heat and humid weather with the arrival of summer but influenza B cases, ...